EuroSIDA Publications 2025

1. Viremia does not independently predict cardiovascular disease in people with HIV: a RESPOND cohort study. Elvstam O, Ryom L, Neesgaard B, Tau L, Günthard H F, Zangerle R, Vehreschild J J, Wit F, Sönnerborg A, Kovari H, Abutidze A, Petoumenos K, Jaschinski J, Hosein S, Bogner J, Grabmeier-Pfistershammer K, Garges H, Rooney J, Young L, Law M, Kirk O for the RESPOND Study Group.
   Open Forum Infectious Diseases 2025. Jan 13;12(2):ofaf016. 
   Abstract
   ​

2. Incident tuberculosis in people with HIV across Europe from 2012-2022: incidence rates, risk factors, and regional differences in a multicentre cohort study. Kraef C, Roen A, Podlekareva D, Bakowska E, Nemeth J, Knappik M, Payen M-C, Wit F, Mussini C, d’Arminio Monforte11 A, Castagna A, Chkhartishvili N, Neesgaard B, Jaschinski1 N, Volny Anne A, Borodulina E, Ballief M, Wallner E, Israelski D, Garges H, Mocroft A, Kirk O and the RESPOND Study Group. 
   European Respiratory Journal 2025. Feb 20:2401904. 
   Abstract
   ​

3. Risk of cancer in people with HIV experiencing varying degrees of immune recovery with sustained virological suppression on antiretroviral treatment for more than 2 years: an international, multicentre, observational cohort. Han WM, Ryom L, Sabin C, Greenberg L, Cavassini M, Egle A, Duvivier C, Wit F, Mussini C, d'Arminio Monforte A, Castagna A, Miro JM, van der Valk M, Bonnet F, Pradier C, Skocic M, Matulionyte R, Stöckle M, Jaschinski N, Timiryasova A, Tallada J, Rogatto FP, Vannappagari V, Young LA, Lundgren JD, Petoumenos K, Hoy JF. 
   Clinical Infectious Diseases 2025. May 15:ciaf248.
   Abstract
   
   ​

Total number of publications: 348